Niagen Bioscience (NAGE) EBT Growth (1y) (2011 - 2026)
Niagen Bioscience (NAGE) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
13.34% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
-51.60% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-313.33% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
-79.57% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
-230.18% |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
71.54% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Niagen Bioscience |
275.31 Mn |
208.77 Mn |
19.98 Mn |
28.75% |
| Date | Value |
|---|
| Mar 31, 2026 |
28.75% |
| Dec 31, 2025 |
-40.89% |
| Sep 30, 2025 |
155.59% |
| Jun 30, 2025 |
25,013.33% |
| Mar 31, 2025 |
1,163.21% |
| Dec 31, 2024 |
6,464.91% |
| Sep 30, 2024 |
295.83% |
| Jun 30, 2024 |
99.32% |
| Mar 31, 2024 |
75.00% |
| Dec 31, 2023 |
107.89% |
| Sep 30, 2023 |
68.76% |
| Jun 30, 2023 |
65.75% |
| Mar 31, 2023 |
74.57% |
| Dec 31, 2022 |
72.88% |
| Sep 30, 2022 |
65.33% |
| Jun 30, 2022 |
-14.93% |
| Mar 31, 2022 |
-4.86% |
| Dec 31, 2021 |
12.66% |
| Sep 30, 2021 |
-110.11% |
| Jun 30, 2021 |
-49.99% |
